Visterra Inc. · 8 hours ago
Senior Scientist, Research (Bioinformatics)
Waltham, MA
Full-time
Onsite
Mid, Senior Level
4+ years expVisterra Inc. is a clinical stage biotechnology company focused on developing innovative antibody-based therapies. The Senior Scientist, Research will lead bioinformatics analyses of genomics and multi-omics datasets to support drug discovery and therapeutic development, employing advanced computational approaches to derive biological insights.
BiotechnologyClinical TrialsHealth DiagnosticsTherapeutics
Hiring Manager
Eric Gaffen
Responsibilities
Develop and implement advanced machine learning and computational strategies, including deep learning, graph-based methods, and probabilistic modeling, to extract insights genomics datasets, including single-cell, spatial and genetic modalities
Collaborate with internal and external scientists and clinicians to drive insights from multi-omic data, supporting novel therapeutic development
Develop new bioinformatics strategies efforts to address key target identification questions on underlying biological mechanisms of disease
Leverage and extend best practices from genomics, statistics, and data science to process and analyze internal and public multi-omics data and derive biological insights that will impact program strategy
Manage existing high-dimensional data resources and ingest new public and internal datasets for use by team members
Clearly communicate complex data findings to colleagues and senior management
Engage in research discussions, proactively suggesting innovative solutions to impact discovery and clinical programs
Stay current with advancements in computational biology by reviewing literature, evaluating new technologies, and implementing relevant methodologies
Present research findings at conferences and publish in scientific journals
Participate in research team meetings, and proactively suggest new ways to impact programs from discovery through the clinic
Maintain expertise in the field by staying current with relevant literature, proactively evaluate new technologies, and implement in-house where appropriate
Qualification
Required
PhD. in Computational Biology, Bioinformatics, Computer Science, or a related field with 4+ years of experience, or a M.S. with 10 years of relevant experience
Expertise in single-cell genomics (scRNA-seq), spatial transcriptomics, genetics or other large-scale multi-dimensional genomics analyses
Deep experience implementing workflows to process high-throughput -omics data and performing downstream analyses that generate biological insights
Proven track record of evaluating and using public biology databases, with an understanding of how to utilize large datasets to drive discovery and development
Deep understanding in computational single cell toolsets such as Seurat, Scanpy, and other relevant methods
Strong programming skills in Python and/or R for bioinformatics applications
Familiarity with cloud computing services, such as AWS
Excellent collaboration and interpersonal skills for multi-disciplinary teamwork
Strong problem-solving abilities, analytical thinking, and intellectual curiosity
Exceptional written and verbal communication skills, with the ability to present complex ideas clearly to diverse audiences
Passion for developing computational technologies for biological research and translating findings into therapeutic applications in precision medicine and translational research
Company
Visterra Inc.
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases.
51-200 employees
H1B Sponsorship
Visterra Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (4)
2023 (2)
2022 (3)
2021 (3)
2020 (4)
Funding
Current Stage
Growth StageTotal Funding
$125.39MKey Investors
Temasek Holdings
2018-07-11Acquired
2017-10-05Series C· $23.6M
2016-06-01Series C· $23.1M
Leadership Team
Brian Pereira
President & CEO & Board Member
P
Peter Courossi
Chief Financial Officer
Recent News
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-12-02
prnasia.com
2025-08-29
Company data provided by crunchbase